Monomeric C-Reactive Protein: Current Perspectives for Utilization and Inclusion as a Prognostic Indicator and Therapeutic Target
Monomeric C-reactive protein (mCRP), once thought to be a figment of the imagination and whose biological activity was ascribed to its sodium azide preservative, has now pronounced itself as a critical molecule playing a direct role in mediating many of the acute and chronic aberrant pathological re...
Main Authors: | Mark Slevin, Nima Heidari, Leonard Azamfirei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.866379/full |
Similar Items
-
Expression of Monomeric C-Reactive Protein in Infarcted Brain Tissue from Patients with Alzheimer’s Disease
by: Mark SLEVIN, et al.
Published: (2017-01-01) -
The Effect of C-Reactive Protein Isoforms on Nitric Oxide Production by U937 Monocytes/Macrophages
by: Nicola R. Sproston, et al.
Published: (2018-07-01) -
Antibody Protection against Long-Term Memory Loss Induced by Monomeric C-Reactive Protein in a Mouse Model of Dementia
by: Elisa García-Lara, et al.
Published: (2021-07-01) -
C-Reactive Protein in Atherothrombosis and Angiogenesis
by: Lina Badimon, et al.
Published: (2018-03-01) -
Editorial: C-Reactive Protein in Age-Related Disorders
by: Mark Slevin, et al.
Published: (2018-11-01)